A detailed history of Dearborn Partners LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Dearborn Partners LLC holds 3,572 shares of NVO stock, worth $399,849. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,572
Previous 3,372 5.93%
Holding current value
$399,849
Previous $432,000 17.82%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

BUY
$122.71 - $146.91 $24,542 - $29,382
200 Added 5.93%
3,572 $509,000
Q4 2023

Jan 26, 2024

BUY
$87.78 - $105.45 $43,890 - $52,725
500 Added 17.41%
3,372 $348,000
Q3 2023

Nov 01, 2023

BUY
$90.94 - $199.54 $130,589 - $286,539
1,436 Added 100.0%
2,872 $261,000
Q1 2023

May 04, 2023

BUY
$132.34 - $159.14 $190,040 - $228,525
1,436 New
1,436 $228,000
Q2 2022

Jul 20, 2022

BUY
$103.24 - $121.81 $185,625 - $219,014
1,798 New
1,798 $200,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $253B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Dearborn Partners LLC Portfolio

Follow Dearborn Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dearborn Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dearborn Partners LLC with notifications on news.